Cargando…

Association between SOCS3 hypermethylation and HBV-related hepatocellular carcinoma and effect of sex and age: A meta-analysis

BACKGROUND: Suppressor 3 of cytokine signaling (SOCS3) hypermethylation has been reported to participate in hepatocellular carcinoma (HCC) development and progression, but conflicting results were published. This study aimed to analyze the clinical effects of SOCS3 hypermethylation in HCC and the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hairu, Yan, Yanggang, Cheng, Jiajia, Yu, Shuyong, Wang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556007/ https://www.ncbi.nlm.nih.gov/pubmed/34713837 http://dx.doi.org/10.1097/MD.0000000000027604

Ejemplares similares

Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study
por: Ding, Xianglian, et al.
Publicado: (2016)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis
por: Zheng, Yu, et al.
Publicado: (2016)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017)

Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Li, Dailong, et al.
Publicado: (2023)

An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma
por: Zhang, X, et al.
Publicado: (2014)

Fibulin-1 Is Downregulated Through Promoter Hypermethylation in Colorectal Cancer: A Consort Study
por: Xu, Zhiying, et al.
Publicado: (2015)

Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: A meta-analysis of prospective studies
por: Liu, Lin, et al.
Publicado: (2016)

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)

Drug-eluting beads versus conventional transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
por: Wang, Zi-Yu, et al.
Publicado: (2023)

Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
por: Chen, Shicheng, et al.
Publicado: (2022)

Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate–advanced hepatocellular carcinoma: A meta-analysis comparing clinical outcomes
por: Xie, Yong, et al.
Publicado: (2021)

Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Shi, Xinhui, et al.
Publicado: (2021)

Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis
por: Wang, Qinjing, et al.
Publicado: (2022)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Tao, Pengxian, et al.
Publicado: (2020)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases
por: Shen, Hujia, et al.
Publicado: (2017)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

The comparison of different antiviral therapies on the prognosis of hepatitis B virus-related hepatocellular carcinoma after curative treatments: A network meta-analysis
por: Xia, Zijing, et al.
Publicado: (2020)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA)
por: Liu, Rui, et al.
Publicado: (2015)

Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis
por: Cui, Kai, et al.
Publicado: (2020)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis
por: Xian, Feng, et al.
Publicado: (2022)

Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis
por: Zhu, Jie, et al.
Publicado: (2023)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

The Epidemiological Investigation on the Risk Factors of Hepatocellular Carcinoma: A Case–Control Study in Southeast China
por: Niu, Jianjun, et al.
Publicado: (2016)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hhamvgqdn3kgm7s44q6rvng6tb